tradingkey.logo

Eli Lilly declines to comment on market talk about Abivax interest

ReutersDec 10, 2025 1:03 PM

Eli Lilly LLY.N:

  • SAYS ON ABIVAX INTEREST SPECULATION: 'WE DO NOT COMMENT ON BUSINESS DEVELOPMENT ACTIVITY'

Further company coverage: LLY.N

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI